CERABSECera Sanitaryware LtdMediumNeutral
Announced Thu, 14 May · 17:59 IST

Q4 FY2026 Earnings call transcript of the conference call held on 9th May, 2026

Mgmt Guided Margin ImprovementInvestor Communications View source PDF

CERA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹5725.00
prior close
₹5745.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4-1.2-1.1-0.4-2.6+1.3+0.8+0.9-0.1+0.4-4.4+9.2+6.5
Up moveDown movePending
AI summary

Cera Sanitaryware reported Q4 FY26 revenue of INR 644 crore, up 11.4% YoY, driven primarily by volume growth of 12%. However, EBITDA margins declined to 15.2% from 18.3% due to elevated brass input costs (up 29-30% YoY) and higher trade discounts. The company implemented price hikes of 12% in sanitaryware and 16% in faucetware over two months to offset cost pressures. For FY27, management guided for 18-20% overall revenue growth, with sanitaryware growing 12% and faucetware 18%. EBITDA margins are expected to improve to 14-15% as trade discount controls take effect. The new brands Senator and Polipluz generated INR 19 crore revenue in FY26 with combined losses of INR 8.5 crore, but are targeted to reach INR 70-80 crore in FY27. The company has INR 853 crore in cash and plans to expand faucetware capacity to 5 lakh pieces per month.

Likely market impact

The company is navigating input cost pressures through price hikes while investing in new brands; shareholders should watch for margin recovery in FY27 as price increases take full effect and trade discounts are controlled.